Back to CRBP

GOLDMAN SACHS GROUP INC → CRBP

GOLDMAN SACHS GROUP INC CRBP Position History

Corbus Pharmaceuticals Holdings, Inc. • Healthcare

Quarters held
12
Latest value
$153K
Q3 2026
Peak value
$774K
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$197K
Q1 2025$110K
Q2 2025$301K
Q3 2025$422K
Q4 2025$386K
Q4 2025$386K
Q1 2026$774K
Q1 2026$100K
Q2 2026$368K
Q2 2026$221K
Q3 2026$720K
Q3 2026$153K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$153K22.4K——
Q3 2026$720K105.6K——
Q2 2026$221K23.6K——
Q2 2026$368K39.3K——
Q1 2026$100K10.7K——
Q1 2026$774K82.5K——
Q4 2025$386K47.4K——
Q4 2025$386K47.4K——
Q3 2025$422K33.4K——
Q2 2025$301K43.7K——
Q1 2025$110K20.8K——
Q1 2025$197K37.2K——

Other funds holding CRBP

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B